Wellington Management Group
NVCR icon

Wellington Management Group’s NovoCure NVCR Stock Holding History

Wellington Management Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-74,001
Closed -$1.2M – 1894
2023
Q3 		$1.2M Sell
74,001
-824
-1% -$23.8K ﹤0.01% 1577
2023
Q2 		$3.11M Buy
+74,825
New +$4.65M ﹤0.01% 1386
2020
Q4 		– Sell
-762,811
Closed -$84.9M – 1984
2020
Q3 		$84.9M Sell
762,811
-1,006,718
-57% -$80.5M 0.02% 563
2020
Q2 		$105M Buy
1,769,529
+807,659
+84% +$53.1M 0.02% 508
2020
Q1 		$64.8M Buy
961,870
+99,520
+12% +$7.86M 0.02% 562
2019
Q4 		$72.7M Buy
+862,350
New +$69.6M 0.02% 661

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wellington Management Group's NVCR Position: Q4 2023 in Review

Wellington Management Group sold out of NovoCure (NVCR) in Q4 2023, closing a stake of 74,001 shares — an estimated $1.2M sold.

Wellington Management Group first reported a position in NVCR in Q4 2019 and held it in 6 quarters. The position peaked at $105M in Q2 2020. 219 funds tracked by Wall St. Rank hold NVCR as of Q4 2023.

  • Wellington Management Group reported no remaining NovoCure position as of Q4 2023 after selling out during the quarter.
  • Wellington Management Group sold 74,001 NovoCure shares in Q4 2023, an estimated $1.2M.
  • Wellington Management Group first reported a position in NovoCure in Q4 2019 and held it in 6 quarters.
  • Wellington Management Group's NovoCure position peaked at $105M in Q2 2020.
  • 219 funds tracked by Wall St. Rank held NovoCure as of Q4 2023.

Based on Wellington Management Group's 13F filing for Q4 2023, filed 12 Feb 2024.